SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group is seeing intense retail speculation and volatility as traders compare its aggressive multi-day rally to past low-float Chinese pump-and-dump cycles. The community is sharply divided between those chasing the parabolic price action for massive gains and those warning of imminent bag-holding risks due to the stock's history of dilution and extreme volatility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense community volatility driven by sector-wide profit-taking and geopolitical concerns, yet bulls remain highly vocal about the stock's long-term potential as an AI infrastructure leader. Traders are actively debating whether recent pullbacks represent a genuine cycle shift or a temporary buying opportunity, with significant sentiment focused on the stock's massive earnings growth and future rerating potential.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is generating significant market buzz as investors closely watch upcoming earnings for signals on infrastructure build-out progress and revenue guidance. While community sentiment is heavily polarized between long-term confidence in the company's vertically integrated AI stack and concerns over sector-wide volatility, traders are intensely focused on how the firms hyperscaler ambitions will perform against competitive peers.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is experiencing significant market interest driven by excitement over its Qwen AI platform and potential cloud monetization, fueling debate among investors over its long-term AI infrastructure value versus lingering geopolitical and e-commerce concerns. Community discussion is sharply divided, featuring both bullish sentiment from traders targeting valuation rerating and bearish warnings from skeptics focused on historical price volatility and persistent skepticism toward Chinese equities.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending after confirming the REGAL clinical trial has reached 78 of the 80 required patient events, signaling that final trial data and unblinding are imminent. The community is actively discussing the potential for a massive short squeeze given high short interest, while long-term investors are focused on the transformative potential of the GPS treatment for AML patients and the prospect of significant institutional interest or a future buyout.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is seeing significant upward momentum as investors react to a new joint development agreement with Turbine-X to provide private power infrastructure for AI-driven data centers. The community is actively debating the stock's high short interest and potential for a squeeze, weighing this bullish AI-sector catalyst against ongoing concerns regarding manufacturing scalability, dilution risks, and previous execution challenges.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing intense volatility and speculative interest, fueled by a mix of heavy short-interest dynamics, institutional accumulation, and ongoing debates about its post-bankruptcy share structure. The community remains sharply divided between those betting on a short squeeze or a turnaround driven by the firm's silicon carbide technology, and skeptical investors who view recent price action as an unsustainable pump linked to dilution concerns.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is experiencing intense community focus following reports of underwhelming Q1 revenue and disappointing robotaxi performance, fueling skepticism over management's execution and the timing of recent share buybacks. Despite record year-over-year revenue growth and positive long-term partnerships with firms like Bosch and Uber, investors are expressing frustration over the stock's stagnant price action and lack of clear guidance.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is capturing investor attention as CEO Jensen Huang joins the presidential delegation to China, a move seen as a major catalyst for potential market access and deal-making. While the broader tech sector faces volatility, the community is actively discussing this strategic summit alongside high-growth expectations ahead of the upcoming earnings report.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) continues to see intense speculative momentum, with investors debating whether the current parabolic rise is a sustainable AI-driven super-cycle or a classic bubble destined for a blow-off top. Community discussion is heavily divided, with bulls leveraging the AI narrative to defend aggressive buying while bears are actively scaling into inverse positions, citing extreme RSI levels and historical cycle comparisons to the dot-com era.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Oil prices remained elevated, with Brent crude near $107 a barrel and WTI above $102 a barrel.</li><li>Markets are closely watching Trump’s May 14-15 summit with Chinese President Xi Jinping.</li><li>Traders now await Wednesday’s producer price index report and speeches from Fed officials Susan Collins and Lorie Logan.</li></ul>U.S. stock futures edged mostly higher late Tuesday as hotter inflation data, surging oil prices and rising Treasury yields kept Wall Street on edge ahead of another key inflation report and U.S. President Donald Trump’s summit with Chinese President Xi Jinping.As of 10:55 p.m. ET, Nasdaq 100 futures rose 0.2% while S&amp;P 500 futures gained 0.1%. Dow futures, meanwhile, reversed earlier gains and traded slightly lower.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust (SPY)</a> was ‘bullish’ amid ‘normal’ message volume, while sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> and&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> was ‘bullish’ amid ‘high’ message volume.<h2 class="st-heading-2">US Market Drivers</h2>Stocks were also weighed down by another sharp surge in oil prices after Trump criticized the ceasefire between the U.S. and Iran as “unbelievably weak” and “on massive life support” after rejecting an “unacceptable” counterproposal from Tehran. “I would call it the weakest, right now, after reading that piece of garbage they sent us — I didn’t even finish reading it,” Trump said.Here’s how the major U.S. indexes fared during Tuesday’s session:&nbsp;<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>0.11%</td><td>49,760.56</td></tr><tr><td>S&amp;P 500</td><td>-0.16%</td><td>7,400.96</td></tr><tr><td>Nasdaq Composite</td><td>-0.71%</td><td>26,088.20</td></tr></tbody></table></figure></div>Brent crude traded near $107 a barrel after rising almost 8% over the past three sessions, while West Texas Intermediate crude hovered near $102.Trump later attempted to calm markets during an interview with&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/FoxNews/status/2054261035519926582">Fox News</a>, saying that oil prices would decline once the war ends.&nbsp; "As soon as this war is over, which will not be long, you're going to see oil prices drop and you're going to see a stock market which is already at the highest point in history, go through the roof.”Markets are also monitoring Trump’s highly anticipated May 14-15 summit with Chinese President Xi Jinping in Beijing, where trade talks are expected to dominate despite the ongoing conflict in Iran. Trump said before departing Washington that trade would be the primary focus of the meeting and said the U.S. had Iran “very much under control.”The summit comes as China remains one of Iran’s largest oil buyers and as global markets continue to grapple with disruptions tied to the Strait of Hormuz blockade. Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-05-12/trump-faces-emboldened-xi-in-china-as-iran-war-clips-us-leverage">reported</a> that Trump is seeking business deals and a possible extension of the trade truce reached with China last fall, while Beijing enters negotiations with stronger leverage tied to its control over critical rare-earth supply chains.Trump called his relationship with Xi “fantastic” and said the two countries were “doing very well.”<h2 class="st-heading-2">Trending Stocks To Watch On NYSE, Nasdaq</h2>Nvidia (NVDA): The stock slipped nearly 1% in after-hours trading after Nvidia confirmed that CEO Jensen Huang joined Trump’s China delegation for trade talks with Xi Jinping after reports that he was initially not invited.Sellas Life Sciences&nbsp;(SLS): The stock jumped 16% in extended trading after the company said its late-stage Regal leukemia trial is now just&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-pops-big-after-hours-on-imminent-leukemia-trial-data-readout-optimism/cZXXrpWRe0T">two patient events</a> away from triggering a topline data readout.Wendy’s&nbsp;(WEN): The stock logged its best day in nearly three months on Tuesday after reports said that activist investor Nelson Peltz’s Trian Fund Management is exploring&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wendy-s-stock-gains-premarket-what-s-driving-the-rally/cZXX4pWReLY">financing options</a> for a potential take-private deal.Work Medical Technology Group&nbsp;(WOK): The stock surged another 70% in after-hours trading after the company unveiled an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-wok-stock-skyrocketed-in-just-2-days/cZXLTxmRe05">AI-biotech partnership</a> and expanded its blockchain-based healthcare infrastructure and “BioToken” initiatives.Red Cat Holdings (RCAT): The stock slumped 10% after hours following the drone technology company's announcement of a $200 million underwritten public stock offering priced between $9.4 and $9.9 per share.Robinhood Ventures Fund I&nbsp;(RVI): The stock hit a record high on Tuesday amid Robinhood’s plans for Robinhood Ventures Fund II, which aims to expand retail investor access to private startups, including OpenAI and Stripe.<h2 class="st-heading-2">How Global Markets Are Performing Today</h2>The yield on the benchmark 10-year Treasury note remained near the key 4.5% level, while gold traded around $4,720 an ounce after inflation data boosted expectations for tighter monetary policy. Silver traded above $87 an ounce and remained one of the strongest-performing precious metals this month.The Kobeissi Letter&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/KobeissiLetter/status/2054221057167634685">said on X</a> that the “U.S. bond market crisis is intensifying,” noting that the 30-year Treasury yield moved above 5% while the benchmark 10-year yield approached the closely watched 4.5% level that previously triggered Trump’s “90-day tariff pause” earlier this year. They also warned that mortgage rates could climb back above 7% if long-term yields continue rising.Among the key catalysts for Wednesday are April’s producer price index report and speeches from Boston Fed President Susan Collins and Dallas Fed President Lorie Logan. Economists polled by Dow Jones expect headline PPI to rise 0.5% month over month, matching March’s pace, while core PPI is expected to increase 0.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump greets Chinese President Xi Jinping ahead of a bilateral meeting at Gimhae Air Base on October 30, 2025 in Busan, South Korea. (Photo by Andrew Harnik/Getty Images)

S&P 500, Nasdaq, Dow Futures Mixed As Markets Digest Trump’s Iran Ceasefire Remarks, Hot Inflation — Why NVDA, WOK, RCAT, SLS, RVI Are In Focus 

Trump attempted to calm investors, saying that oil prices would fall once the war in Iran ends, and added that the stock market would “go through the roof.”

Equity

<ul class="summary-bullets"><li>On Monday, Work Medical announced a partnership with Shanghai Novabioplus Biotechnology to develop AI-powered healthcare and drug discovery systems.</li><li>The deal includes AI-based projects involving protein design, antibody optimization, enzyme engineering and peptide development.</li><li>Investors also focused on the company’s new “BioToken” concept, which involves creating blockchain-based digital biological assets.</li></ul>Shares of Work Medical Technology Group (WOK) skyrocketed nearly 300% so far this week after the China-based medical device company announced an AI biotech partnership and expanded its push into blockchain-based healthcare infrastructure.<a href="https://stocktwits.com/symbol/WOK">WOK stock</a> surged more than 200% on Monday after the partnership announcement and gained another 70% on Tuesday. The rally continued in Tuesday’s after-hours session, with shares jumping another 70% to become the session’s top after-hours gainer.&nbsp;<h2 class="st-heading-2">WOK AI Healthcare Deal Fuels Rally</h2>The rally accelerated after Work Medical said on Monday that it had struck a deal with Shanghai Novabioplus Biotechnology to develop AI-based healthcare and drug discovery systems using biological datasets. The two companies plan to combine Work Medical’s healthcare AI tech with Novabioplus’ protein research databases and lab platforms to build advanced medical models and improve biotech research and development.According to the company, the partnership strengthens its broader “Healthcare + Web3 + AI” strategy, particularly in biopharmaceutical research. The collaboration includes four major AI-focused projects involving protein structure design, antibody optimization, enzyme engineering and peptide development. The companies said the goal is to use AI to analyze complex biological data, improve molecular design and speed up parts of the drug discovery process.Work Medical said that the partnership could also support the development of AI-assisted protein and antibody therapies by combining its AI algorithms with Novabioplus’ protein datasets and biological research infrastructure.<h2 class="st-heading-2">Work Medical’s ‘BioToken’ Push&nbsp;</h2>WOK shares drew particular attention after the company introduced the concept of “BioTokens,” blockchain-based digital assets tied to biological datasets and protein therapeutics. Work Medical said that the deal with Novabioplus aims to generate AI-driven multimodal biological data “BioTokens” by integrating protein sequences, functional biological data and laboratory datasets into AI models for protein molecular design.The company said the platform is expected to optimize protein structures and improve biological functions, while generating digital biological assets with “assetization potential.” According to Work Medical, the BioToken model could transform biopharmaceutical research outputs into “verifiable and measurable digital assets.”<h2 class="st-heading-2">WOK Deepens Web3 Strategy</h2>The latest AI-biotech announcement comes after several blockchain and tokenization initiatives unveiled by the company this year. Earlier this month, Work Medical said it had been formally awarded a Council Member certificate as a Vice President Unit of the Hong Kong Web3.0 Standardization Association, an organization focused on Web3 standardization research.The announcement came after Hong Kong implemented its stablecoin regulatory framework in August 2025, which Work Medical said accelerated interest among Chinese-listed companies exploring blockchain integration and asset tokenization. Work Medical said it has been advancing a broader strategy involving healthcare real-world asset tokenization, AI Agent-to-Agent payments and stablecoin-enabled cross-border settlement systems to create digital infrastructure for medical assets.The company added that it contributed to an Asset Tokenization Whitepaper released during the Web3.0 Standardization and Globalization Summit in Hong Kong in April. According to Work Medical, the whitepaper established foundational standards for industrial asset digitization and compliance frameworks for healthcare-related digital assets.Work Medical said the company is transitioning from a traditional medical consumables supplier into a builder of “next-generation medical infrastructure powered by AI and blockchain.”<h2 class="st-heading-2">AI Blood Analyzer Added Early Buzz</h2>Investor interest in Work Medical’s AI ambitions had already started building late last year after the commercialization rollout of its AI-Automated Blood Cell Morphology Analyzer in China. In December, the company said that its unit, Hunan Saitumofei Medical Treatment Technology, had entered into a one-year exclusive distribution agreement with Shanghai Benke Medical Technology to distribute the analyzer throughout East China in 2026.The agreement covered Jiangsu Province, Shanghai Municipality and Zhejiang Province and included a minimum annual sales target of 10 million yuan ($1.5 million). The analyzer received Class II medical device manufacturing approval from Chinese regulators in November and uses AI-driven automation and high-resolution digital imaging technology to identify and classify blood cells.According to the company, the system can process up to 150 samples at a time, identify 17 different types of white blood cells and analyze a blood smear in about three minutes on average. Work Medical said the analyzer can store over 350,000 high-definition blood cell images and uses AI-based image analysis tech to make results easier for medical professionals to interpret, while helping reduce potential diagnostic risks.<h2 class="st-heading-2">How Do Retail Traders Feel About WOK?</h2>On Stocktwits, retail sentiment for WOK was ‘extremely bullish’ amid a massive 34,275% surge in message volumes over the past three months. The stock’s retail watcher base has also jumped 30% in a week.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/wok_ss_png_0a50f4ed37.webp" alt="wok ss.png" width="972" height="149"><figcaption>WOK sentiment and message volume as of May 12 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Bleedner/message/653155109">outlined</a> their trading strategy and said, “Out at $9, will look for re-entry tomorrow, but this thing has been wildddd. Up 4,500% since lows of yesterday.”<stembedurl>https://stocktwits.com/Bleedner/message/653155109</stembedurl>Another user said WOK stock could “just run the rest of the week” and compared the rally to an earlier surge in cannabis company AKAN.&nbsp;<stembedurl>https://stocktwits.com/JdNews/message/653155574</stembedurl>WOK stock crashed 99.9% over the past year, but surged 206% since January.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-pops-big-after-hours-on-imminent-leukemia-trial-data-readout-optimism/cZXXrpWRe0T">SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism&nbsp;</a>

WOK stock crashed 99.9% over the past year, but surged 206% since January. (Photo credit: Getty Images)

Why Did WOK Stock Skyrocket Nearly 300% In Just 2 Days?

The company is building infrastructure involving healthcare asset tokenization, AI Agent-to-Agent payments, and stablecoin-enabled settlement for medical assets.

What's Going On With WORK Medical Technology Group Stock Today?

Shares of WORK Medical are rising Monday after the company received manufacturing approval for one of its AI-powered products.read more...

<ul class="summary-bullets"><li>The system combines advanced imaging with AI software to analyze blood smears, conduct white blood cell counts, and assess red blood cells and platelets.</li><li>The company expects to begin manufacturing the analyzer in the first half of 2026.</li><li>Work Medical Technology had announced a 1-for-100 reverse stock split last week to comply with Nasdaq’s minimum price rule.</li></ul>Work Medical Technology Group (WOK) shares jumped more than 50% on Monday, before paring some of the gains, after the company secured Chinese regulatory approval to manufacture an AI-powered blood analysis device. At the same time, the stock also began trading on a reverse split basis.Work’s China-based subsidiary has secured regulatory approval from the Hunan Provincial Medical Products Administration to manufacture a Class II AI-powered medical device, called the AI-Automated Human Blood Cell Morphology Analyzer.The system combines advanced imaging hardware with AI software to analyze blood smears and perform white blood cell differential counts, while also assessing red blood cells and platelets. It will use deep-learning algorithms and a fully automated workflow to improve accuracy and consistency in laboratory testing. Work Medical expects to begin manufacturing the analyzer in the first half of 2026.Work’s CEO and chairman, Shuang Wu, expects that, with ongoing AI upgrades and deeper workflow integration, the device will become standard equipment across hospital hematology and oncology departments as well as primary-care labs.“We are optimistic about this product line’s growth and its revenue potential for the company,” Shuang Wu said.<h2 class="st-heading-2">1-For-100 Reverse Split</h2>Last week, <a href="https://stocktwits.com/symbol/WOK">Work Medical</a> said it would implement a 1-for-100 reverse stock split of its ordinary shares, effective on December 29. This resulted in every 100 shares of the company’s outstanding Class A and Class B ordinary shares being combined into one ordinary share. The move is aimed at maintaining compliance with Nasdaq’s minimum bid price requirement of $1.00.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits surrounding the stock shifted to ‘bullish’ from ‘bearish’ a day earlier.One user expects support at $3.87.<stembedurl>https://stocktwits.com/Zackpedia/message/640305180</stembedurl>Another user sees strong upside.<stembedurl>https://stocktwits.com/trading_momentum_x/message/640304021</stembedurl>Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/silver-pullback-from-80-drives-hl-ag-paas-stock-lower/cL75u1sRExP">Silver’s $80 Breach Sparks Strong Pullback, Miners Feel The Heat: HL, AG, PAAS Stocks Drop Premarket</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

Why Did WOK Stock Surge Over 50% Today?

The company’s unit secured Chinese approval for an AI-powered blood analysis device, and the stock also began trading on a reverse-split basis from Monday.

Retail investors are debating whether the recent extreme price volatility is a legitimate short squeeze or a orchestrated Chinese pump-and-dump scheme.

Traders are closely watching the stock's extremely low float and massive volume, which has fueled aggressive and often volatile intraday price spikes.

Veterans are warning late-chasing traders about the historical pattern of these stocks, citing risks of reverse splits, dilution, and rapid corrections to penny levels.

High short interest and borrowing fees have turned the stock into a battleground between those expecting a massive blow-up and those betting on a total collapse.

WOK
Work Medical Technology Group Ltd

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest WOK News

WOKWork Medical Technology Group Ltd